Eliana Clark - Jul 1, 2025 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
EVP, Chief Technical Officer
Signature
/s/ James Basta, attorney-in-fact
Stock symbol
NTLA
Transactions as of
Jul 1, 2025
Transactions value $
-$10,036
Form type
4
Date filed
7/3/2025, 04:11 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Clark Eliana EVP, Chief Technical Officer C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE /s/ James Basta, attorney-in-fact 2025-07-03 0001914448

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale -$10K -1.02K -1.06% $9.82 95.4K Jul 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of 1,022 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025.